U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C5H9O2.Zn
Molecular Weight 267.657
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ZINC VALERATE

SMILES

[Zn++].CCCCC([O-])=O.CCCCC([O-])=O

InChI

InChIKey=BUDAIZWUWHWZPQ-UHFFFAOYSA-L
InChI=1S/2C5H10O2.Zn/c2*1-2-3-4-5(6)7;/h2*2-4H2,1H3,(H,6,7);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula C5H9O2
Molecular Weight 101.1238
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Zn
Molecular Weight 65.409
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Valeric acid is a colorless, oily liquid with an unpleasant odor. It is highly corrosive and must be handled with care. Valeric acid is mainly used as a chemical intermediate to manufacture flavors and perfumes, synthetic lubricants, agricultural chemicals, and pharmaceuticals. It is also used as a flavoring aid in foods. Valeric acid is considered safe as a food additive by the World Health Organization.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin.
1999 Sep
Microflora-associated characteristics in faeces from allergic and nonallergic infants.
2000 Nov
Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil.
2001
Effect of the liquid upflow velocity on thermophilic sulphate reduction in acidifying granular sludge reactors.
2001 Feb
Effect of ruminal vs postruminal administration of degradable protein on utilization of low-quality forage by beef steers.
2001 Jan
Aroma-active components of nonfat dry milk.
2001 Jun
A two-choice discrimination method to assess olfactory performance in pigtailed macaques, Macaca nemestrina.
2001 Mar
Rumen microbial sequestration of [2-(13)C]acetate in cattle.
2001 Sep
Comparative study of differentiation levels and valepotriate content of in vitro cultures and regenerated and wild plants of Valeriana edulis ssp.procera.
2002 Apr
Influence of yeast culture on ruminal microbial metabolism in continuous culture.
2002 Aug
Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial.
2002 Dec 21-28
Severe hypertriglyceridemia and pancreatitis following hormone replacement prior to cryothaw transfer.
2002 Feb
Mesophilic acidification of gelatinaceous wastewater.
2002 Feb 14
Development of a headspace solid-phase microextraction-gas chromatography-mass spectrometry method for the identification of odour-causing volatile compounds in packaging materials.
2002 Jul 19
Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycle.
2002 Mar
Evidence for a compound in Comstock-Kellog glands modulating premating behavior in male desert locust, Schistocerca gregaria.
2002 May
Liquefaction and methanization of solid and liquid coffee wastes by two phase anaerobic digestion process.
2003
Psychophysical evaluation of responses to pleasant and mal-odour stimulation in human subjects; adaptation, dose response and gender differences.
2003 Apr
Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids.
2003 Apr 18
Conformationally constrained analogues of bleomycin A5.
2003 Aug 27
Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial.
2003 Jul
[Anti-arrhythmia activity of estradiol valerate and estradiol nitrate].
2003 May-Jun
Mecamylamine reduces nicotine cross-desensitization of trigeminal caudalis neuronal responses to oral chemical irritation.
2003 Nov 21
Regulation of glucose-6-phosphatase gene expression in cultured hepatocytes and H4IIE cells by short-chain fatty acids: role of hepatic nuclear factor-4alpha.
2003 Oct 17
Kinetics of thermophilic, anaerobic oxidation of straight and branched chain butyrate and valerate.
2003 Oct 20
Sequential feeding of glucose and valerate in a fed-batch culture of Ralstonia eutropha for production of poly(hydroxybutyrate-co-hydroxyvalerate) with high 3-hydroxyvalerate fraction.
2004 Jan-Feb
Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids.
2004 Mar
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
1.5 mM valeric acid is an effective chemical reagent to increase mAb production in rCHO cells.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:02:33 GMT 2023
Edited
by admin
on Fri Dec 15 16:02:33 GMT 2023
Record UNII
HHJ036TQR0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZINC VALERATE
MI   WHO-DD  
Systematic Name English
PENTANOIC ACID ZINC SALT
Common Name English
ZINC VALERIANATE
Common Name English
ZINC VALERATE [MI]
Common Name English
Zinc Valerate [WHO-DD]
Common Name English
Code System Code Type Description
ECHA (EC/EINECS)
209-124-1
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
PUBCHEM
68393
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
RXCUI
1546360
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY RxNorm
EPA CompTox
DTXSID00890509
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
MERCK INDEX
m11634
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY Merck Index
DAILYMED
HHJ036TQR0
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
CAS
556-38-7
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
SMS_ID
100000145791
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
FDA UNII
HHJ036TQR0
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
EVMPD
SUB124575
Created by admin on Fri Dec 15 16:02:33 GMT 2023 , Edited by admin on Fri Dec 15 16:02:33 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY